Alaunos Therapeutics (TCRT) EBT Margin (2009 - 2025)
Alaunos Therapeutics (TCRT) recorded EBT Margin of -30233.33% in Q4 2025, down 11358.33 percentage points from -18875.00% a year earlier.
Alaunos Therapeutics (TCRT) EBT Margin (2009 - 2025) Analysis & Trends
For FY2025, Alaunos Therapeutics reported EBT Margin of -84500.00%, down 36380.00 percentage points from FY2024.
- Annual EBT Margin has a four-year change of -64812.75 percentage points (FY2021 to FY2025).
- Across earlier years, EBT Margin came in at -48120.00% in FY2024 (+675640.00 pp), -723760.00% in FY2023 (-722449.08 pp), -1310.92% in FY2022 (+18376.33 pp) and -19687.25% in FY2021.
- Quarterly EBT Margin has ranged from -794900.00% in Q4 2023 to -312.78% in Q3 2022 over the past five years.
- On a year-over-year basis, EBT Margin rose in three of the last four quarters, with an average year-over-year change of +270341.67 percentage points.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Alaunos Therapeutics | 4.16 Mn | 357,198.54 | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -30,233.33% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -18,875.00% |
| Jun 30, 2024 | -29,150.00% |
| Mar 31, 2024 | -174,200.00% |
| Dec 31, 2023 | -794,900.00% |
| Jun 30, 2023 | -226,250.00% |
| Dec 31, 2022 | -85,645.45% |
| Sep 30, 2022 | -312.78% |
| Dec 31, 2021 | -590,350.00% |
| Sep 30, 2021 | -5,713.57% |
| Mar 31, 2018 | -11,093.15% |
| Dec 31, 2017 | -841.33% |
| Sep 30, 2017 | -818.40% |
| Jun 30, 2017 | -814.90% |
| Mar 31, 2017 | -874.45% |
| Dec 31, 2016 | -695.74% |
| Sep 30, 2016 | -682.98% |
| Jun 30, 2016 | -7,733.77% |
| Mar 31, 2016 | -611.48% |
Alaunos Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();